Follow the people · Insider
Andrew D. Dickinson
Andrew D. Dickinson files insider transactions with the SEC as a chief financial officer of Gilead Sciences (GILD). We hold 8 disclosed purchases and sales filed since 2 February 2006, 3 of them in the last 90 days.
- Files forGILD
- Disclosed buys and sells8 in all, 3 in the last 90 days
- Last disclosure18 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 10 November 2019 — 17 August 2026Chief Financial Officer · Gilead Sciences (GILD)219 Form 4 lines · source: SEC Form 4
- Filed 31 January 2006 — 17 November 2006Former VP, Gen. Counsel & Sec · Myogen (MYOG)8 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 416 July 2026Common Stock · traded 15 July 2026 · filed 16 July 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 416 June 2026Common Stock · traded 15 June 2026 · filed 16 June 2026
- exercised options over 2,796 shares of Gilead SciencesSEC Form 411 June 2026Common Stock · traded 10 June 2026 · filed 11 June 2026
- had shares withheld for tax on 1,341 shares of Gilead SciencesSEC Form 411 June 2026Common Stock · traded 10 June 2026 · filed 11 June 2026
- exercised options over 2,796 shares of Gilead Sciences (a derivative holding)SEC Form 411 June 2026Restricted Stock Unit · traded 10 June 2026 · filed 11 June 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 418 May 2026Common Stock · traded 15 May 2026 · filed 18 May 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 416 April 2026Common Stock · traded 15 April 2026 · filed 16 April 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- exercised options over 6,469 shares of Gilead SciencesSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- had shares withheld for tax on 3,147 shares of Gilead SciencesSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- exercised options over 6,469 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2026Restricted Stock Unit · traded 10 March 2026 · filed 12 March 2026
- exercised options over 6,469 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2026Restricted Stock Unit · traded 10 March 2026 · filed 12 March 2026
- was granted 9,590 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2026Restricted Stock Unit · traded 10 March 2026 · filed 12 March 2026
- was granted 35,880 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2026Non-qualified Stock Option (Right to Buy) · traded 10 March 2026 · filed 12 March 2026
- was granted 9,590 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2026Restricted Stock Unit · traded 10 March 2026 · filed 12 March 2026
- was granted 35,880 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2026Non-qualified Stock Option (Right to Buy) · traded 10 March 2026 · filed 12 March 2026
- exercised options over 6,469 shares of Gilead SciencesSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- had shares withheld for tax on 3,147 shares of Gilead SciencesSEC Form 412 March 2026Common Stock · traded 10 March 2026 · filed 12 March 2026
- was granted 11,090 shares of Gilead SciencesSEC Form 42 March 2026Common Stock · traded 27 February 2026 · filed 2 March 2026
- was granted 11,090 shares of Gilead SciencesSEC Form 42 March 2026Common Stock · traded 27 February 2026 · filed 2 March 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 418 February 2026Common Stock · traded 17 February 2026 · filed 18 February 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 418 February 2026Common Stock · traded 17 February 2026 · filed 18 February 2026
- was granted 44,867 shares of Gilead SciencesSEC Form 45 February 2026Common Stock · traded 3 February 2026 · filed 5 February 2026
- had shares withheld for tax on 24,802 shares of Gilead SciencesSEC Form 45 February 2026Common Stock · traded 3 February 2026 · filed 5 February 2026
- was granted 44,867 shares of Gilead SciencesSEC Form 45 February 2026Common Stock · traded 3 February 2026 · filed 5 February 2026
- had shares withheld for tax on 24,802 shares of Gilead SciencesSEC Form 45 February 2026Common Stock · traded 3 February 2026 · filed 5 February 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 416 January 2026Common Stock · traded 15 January 2026 · filed 16 January 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 416 January 2026Common Stock · traded 15 January 2026 · filed 16 January 2026
- ▼ sold on the open market 3,000 shares of Gilead SciencesSEC Form 416 December 2025Common Stock · traded 15 December 2025 · filed 16 December 2025
- exercised options over 3,693 shares of Gilead Sciences (a derivative holding)SEC Form 411 December 2025Restricted Stock Unit · traded 10 December 2025 · filed 11 December 2025
- exercised options over 3,693 shares of Gilead SciencesSEC Form 411 December 2025Common Stock · traded 10 December 2025 · filed 11 December 2025
- had shares withheld for tax on 1,745 shares of Gilead SciencesSEC Form 411 December 2025Common Stock · traded 10 December 2025 · filed 11 December 2025
- ▼ sold on the open market 2,500 shares of Gilead SciencesSEC Form 418 November 2025Common Stock · traded 17 November 2025 · filed 18 November 2025
- ▼ sold on the open market 2,500 shares of Gilead SciencesSEC Form 416 October 2025Common Stock · traded 15 October 2025 · filed 16 October 2025
- ▼ sold on the open market 2,500 shares of Gilead SciencesSEC Form 416 September 2025Common Stock · traded 15 September 2025 · filed 16 September 2025
- exercised options over 3,696 shares of Gilead Sciences (a derivative holding)SEC Form 411 September 2025Restricted Stock Unit · traded 10 September 2025 · filed 11 September 2025
- exercised options over 3,696 shares of Gilead SciencesSEC Form 411 September 2025Common Stock · traded 10 September 2025 · filed 11 September 2025
- had shares withheld for tax on 1,751 shares of Gilead SciencesSEC Form 411 September 2025Common Stock · traded 10 September 2025 · filed 11 September 2025
- ▼ sold on the open market 2,500 shares of Gilead SciencesSEC Form 418 August 2025Common Stock · traded 15 August 2025 · filed 18 August 2025
- ▼ sold on the open market 2,500 shares of Gilead SciencesSEC Form 416 July 2025Common Stock · traded 15 July 2025 · filed 16 July 2025
- ▼ sold on the open market 2,500 shares of Gilead SciencesSEC Form 417 June 2025Common Stock · traded 16 June 2025 · filed 17 June 2025
- exercised options over 3,694 shares of Gilead Sciences (a derivative holding)SEC Form 411 June 2025Restricted Stock Unit · traded 10 June 2025 · filed 11 June 2025
- exercised options over 3,694 shares of Gilead SciencesSEC Form 411 June 2025Common Stock · traded 10 June 2025 · filed 11 June 2025
- had shares withheld for tax on 1,758 shares of Gilead SciencesSEC Form 411 June 2025Common Stock · traded 10 June 2025 · filed 11 June 2025
- ▼ sold on the open market 2,500 shares of Gilead SciencesSEC Form 416 May 2025Common Stock · traded 15 May 2025 · filed 16 May 2025
- ▼ sold on the open market 2,500 shares of Gilead SciencesSEC Form 416 April 2025Common Stock · traded 15 April 2025 · filed 16 April 2025
- ▼ sold on the open market 2,500 shares of Gilead SciencesSEC Form 418 March 2025Common Stock · traded 17 March 2025 · filed 18 March 2025
- exercised options over 4,916 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2025Non-qualified Stock Option (Right to Buy) · traded 10 March 2025 · filed 12 March 2025
- exercised options over 13,013 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2025Non-qualified Stock Option (Right to Buy) · traded 10 March 2025 · filed 12 March 2025
- exercised options over 7,968 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2025Restricted Stock Unit · traded 10 March 2025 · filed 12 March 2025
- was granted 49,020 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2025Non-qualified Stock Option (Right to Buy) · traded 10 March 2025 · filed 12 March 2025
- was granted 11,090 shares of Gilead Sciences (a derivative holding)SEC Form 412 March 2025Restricted Stock Unit · traded 10 March 2025 · filed 12 March 2025
- exercised options over 4,916 shares of Gilead SciencesSEC Form 412 March 2025Common Stock · traded 10 March 2025 · filed 12 March 2025
- exercised options over 13,013 shares of Gilead SciencesSEC Form 412 March 2025Common Stock · traded 10 March 2025 · filed 12 March 2025
- ▼ sold on the open market 4,916 shares of Gilead SciencesSEC Form 412 March 2025Common Stock · traded 10 March 2025 · filed 12 March 2025
- ▼ sold on the open market 13,013 shares of Gilead SciencesSEC Form 412 March 2025Common Stock · traded 10 March 2025 · filed 12 March 2025
- exercised options over 7,968 shares of Gilead SciencesSEC Form 412 March 2025Common Stock · traded 10 March 2025 · filed 12 March 2025
- had shares withheld for tax on 3,855 shares of Gilead SciencesSEC Form 412 March 2025Common Stock · traded 10 March 2025 · filed 12 March 2025
- ▼ sold on the open market 2,500 shares of Gilead SciencesSEC Form 419 February 2025Common Stock · traded 18 February 2025 · filed 19 February 2025
- exercised options over 77,691 shares of Gilead Sciences (a derivative holding)SEC Form 413 February 2025Non-qualified Stock Option (Right to Buy) · traded 12 February 2025 · filed 13 February 2025
- exercised options over 26,175 shares of Gilead Sciences (a derivative holding)SEC Form 413 February 2025Non-qualified Stock Option (Right to Buy) · traded 12 February 2025 · filed 13 February 2025
- exercised options over 15,600 shares of Gilead Sciences (a derivative holding)SEC Form 413 February 2025Non-qualified Stock Option (Right to Buy) · traded 12 February 2025 · filed 13 February 2025
- exercised options over 18,210 shares of Gilead Sciences (a derivative holding)SEC Form 413 February 2025Non-qualified Stock Option (Right to Buy) · traded 12 February 2025 · filed 13 February 2025
- exercised options over 77,691 shares of Gilead SciencesSEC Form 413 February 2025Common Stock · traded 12 February 2025 · filed 13 February 2025
- exercised options over 26,175 shares of Gilead SciencesSEC Form 413 February 2025Common Stock · traded 12 February 2025 · filed 13 February 2025
- exercised options over 15,600 shares of Gilead SciencesSEC Form 413 February 2025Common Stock · traded 12 February 2025 · filed 13 February 2025
- exercised options over 18,210 shares of Gilead SciencesSEC Form 413 February 2025Common Stock · traded 12 February 2025 · filed 13 February 2025
- ▼ sold on the open market 137,676 shares of Gilead SciencesSEC Form 413 February 2025Common Stock · traded 12 February 2025 · filed 13 February 2025
- was granted 19,793 shares of Gilead SciencesSEC Form 46 February 2025Common Stock · traded 4 February 2025 · filed 6 February 2025
- was granted 64,695 shares of Gilead SciencesSEC Form 46 February 2025Common Stock · traded 4 February 2025 · filed 6 February 2025
- had shares withheld for tax on 43,138 shares of Gilead SciencesSEC Form 46 February 2025Common Stock · traded 4 February 2025 · filed 6 February 2025
- exercised options over 26,170 shares of Gilead Sciences (a derivative holding)SEC Form 43 February 2025Non-qualified Stock Option (Right to Buy) · traded 31 January 2025 · filed 3 February 2025
- exercised options over 71,850 shares of Gilead Sciences (a derivative holding)SEC Form 43 February 2025Non-qualified Stock Option (Right to Buy) · traded 31 January 2025 · filed 3 February 2025
- exercised options over 44,160 shares of Gilead Sciences (a derivative holding)SEC Form 43 February 2025Non-qualified Stock Option (Right to Buy) · traded 31 January 2025 · filed 3 February 2025
- exercised options over 26,170 shares of Gilead SciencesSEC Form 43 February 2025Common Stock · traded 31 January 2025 · filed 3 February 2025
- exercised options over 71,850 shares of Gilead SciencesSEC Form 43 February 2025Common Stock · traded 31 January 2025 · filed 3 February 2025
- exercised options over 44,160 shares of Gilead SciencesSEC Form 43 February 2025Common Stock · traded 31 January 2025 · filed 3 February 2025
- ▼ sold on the open market 142,180 shares of Gilead SciencesSEC Form 43 February 2025Common Stock · traded 31 January 2025 · filed 3 February 2025
- ▼ sold on the open market 2,500 shares of Gilead SciencesSEC Form 416 January 2025Common Stock · traded 15 January 2025 · filed 16 January 2025
- ▼ sold on the open market 8,500 shares of Gilead SciencesSEC Form 417 December 2024Common Stock · traded 16 December 2024 · filed 17 December 2024
- exercised options over 3,640 shares of Gilead Sciences (a derivative holding)SEC Form 411 December 2024Restricted Stock Unit · traded 10 December 2024 · filed 11 December 2024
- exercised options over 3,640 shares of Gilead SciencesSEC Form 411 December 2024Common Stock · traded 10 December 2024 · filed 11 December 2024
- had shares withheld for tax on 1,686 shares of Gilead SciencesSEC Form 411 December 2024Common Stock · traded 10 December 2024 · filed 11 December 2024
- exercised options over 26,170 shares of Gilead Sciences (a derivative holding)SEC Form 43 December 2024Non-qualified Stock Option (Right to Buy) · traded 29 November 2024 · filed 3 December 2024
- exercised options over 18,630 shares of Gilead Sciences (a derivative holding)SEC Form 43 December 2024Non-qualified Stock Option (Right to Buy) · traded 29 November 2024 · filed 3 December 2024
- exercised options over 33,660 shares of Gilead Sciences (a derivative holding)SEC Form 43 December 2024Non-qualified Stock Option (Right to Buy) · traded 29 November 2024 · filed 3 December 2024
- exercised options over 60,885 shares of Gilead Sciences (a derivative holding)SEC Form 43 December 2024Non-qualified Stock Option (Right to Buy) · traded 29 November 2024 · filed 3 December 2024
- exercised options over 43,340 shares of Gilead Sciences (a derivative holding)SEC Form 43 December 2024Non-qualified Stock Option (Right to Buy) · traded 29 November 2024 · filed 3 December 2024
- exercised options over 65,960 shares of Gilead Sciences (a derivative holding)SEC Form 43 December 2024Non-qualified Stock Option (Right to Buy) · traded 29 November 2024 · filed 3 December 2024
- exercised options over 18,630 shares of Gilead SciencesSEC Form 43 December 2024Common Stock · traded 29 November 2024 · filed 3 December 2024
- exercised options over 26,170 shares of Gilead SciencesSEC Form 43 December 2024Common Stock · traded 29 November 2024 · filed 3 December 2024
- exercised options over 33,660 shares of Gilead SciencesSEC Form 43 December 2024Common Stock · traded 29 November 2024 · filed 3 December 2024
- exercised options over 60,885 shares of Gilead SciencesSEC Form 43 December 2024Common Stock · traded 29 November 2024 · filed 3 December 2024
- exercised options over 43,340 shares of Gilead SciencesSEC Form 43 December 2024Common Stock · traded 29 November 2024 · filed 3 December 2024
- exercised options over 65,960 shares of Gilead SciencesSEC Form 43 December 2024Common Stock · traded 29 November 2024 · filed 3 December 2024
- ▼ sold on the open market 120,715 shares of Gilead SciencesSEC Form 43 December 2024Common Stock · traded 29 November 2024 · filed 3 December 2024
- ▼ sold on the open market 127,930 shares of Gilead SciencesSEC Form 43 December 2024Common Stock · traded 29 November 2024 · filed 3 December 2024
- exercised options over 3,641 shares of Gilead Sciences (a derivative holding)SEC Form 411 September 2024Restricted Stock Unit · traded 10 September 2024 · filed 11 September 2024
- exercised options over 3,641 shares of Gilead SciencesSEC Form 411 September 2024Common Stock · traded 10 September 2024 · filed 11 September 2024
- had shares withheld for tax on 1,682 shares of Gilead SciencesSEC Form 411 September 2024Common Stock · traded 10 September 2024 · filed 11 September 2024
- exercised options over 3,639 shares of Gilead Sciences (a derivative holding)SEC Form 411 June 2024Restricted Stock Unit · traded 10 June 2024 · filed 11 June 2024
- exercised options over 3,639 shares of Gilead SciencesSEC Form 411 June 2024Common Stock · traded 10 June 2024 · filed 11 June 2024
- had shares withheld for tax on 1,662 shares of Gilead SciencesSEC Form 411 June 2024Common Stock · traded 10 June 2024 · filed 11 June 2024
- exercised options over 3,025 shares of Gilead Sciences (a derivative holding)SEC Form 411 March 2024Restricted Stock Unit · traded 10 March 2024 · filed 11 March 2024
- exercised options over 6,707 shares of Gilead Sciences (a derivative holding)SEC Form 411 March 2024Restricted Stock Unit · traded 10 March 2024 · filed 11 March 2024
- was granted 87,970 shares of Gilead Sciences (a derivative holding)SEC Form 411 March 2024Non-qualified Stock Option (Right to Buy) · traded 10 March 2024 · filed 11 March 2024
- was granted 17,305 shares of Gilead Sciences (a derivative holding)SEC Form 411 March 2024Restricted Stock Unit · traded 10 March 2024 · filed 11 March 2024
- exercised options over 3,025 shares of Gilead SciencesSEC Form 411 March 2024Common Stock · traded 10 March 2024 · filed 11 March 2024
- exercised options over 6,707 shares of Gilead SciencesSEC Form 411 March 2024Common Stock · traded 10 March 2024 · filed 11 March 2024
- had shares withheld for tax on 4,505 shares of Gilead SciencesSEC Form 411 March 2024Common Stock · traded 10 March 2024 · filed 11 March 2024
- was granted 19,006 shares of Gilead SciencesSEC Form 42 February 2024Common Stock · traded 31 January 2024 · filed 2 February 2024
- was granted 55,955 shares of Gilead SciencesSEC Form 42 February 2024Common Stock · traded 31 January 2024 · filed 2 February 2024
- had shares withheld for tax on 23,410 shares of Gilead SciencesSEC Form 42 February 2024Common Stock · traded 31 January 2024 · filed 2 February 2024
- ▼ sold on the open market 5,000 shares of Gilead SciencesSEC Form 417 January 2024Common Stock · traded 16 January 2024 · filed 17 January 2024
- exercised options over 2,617 shares of Gilead Sciences (a derivative holding)SEC Form 411 December 2023Restricted Stock Unit · traded 10 December 2023 · filed 11 December 2023
- exercised options over 2,617 shares of Gilead SciencesSEC Form 411 December 2023Common Stock · traded 10 December 2023 · filed 11 December 2023
- had shares withheld for tax on 1,194 shares of Gilead SciencesSEC Form 411 December 2023Common Stock · traded 10 December 2023 · filed 11 December 2023
- exercised options over 1,912 shares of Gilead Sciences (a derivative holding)SEC Form 413 November 2023Restricted Stock Unit · traded 10 November 2023 · filed 13 November 2023
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.